MKI67 and neoplasm: In a previous report on patients with breast cancer, the total hemoglobin measured by US-DOT was correlated with tumor size and several molecular biomarkers (HER2 and Ki-67), and it was shown to have potential for predicting tumor aggressiveness [21].